Log In
Print this Print this

Acelarin (MTL-007, NUC-1031)

  Manage Alerts
Collapse Summary General Information
Company Morvus Technology Ltd.
DescriptionModified version of gemcitabine using ProTide technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerNuCana BioMed Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today